Advanced Search

NSCLC EGFR-Targeted Therapies: The Oncology Pharmacist's Role in Tailoring Therapy and Improving Patient Outcomes (0 User Ratings) Lung cancer is the most common cancer worldwide, as well as the leading cause of cancer death.1 Non small-cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases, and is... Faculty Philip Schwieterman, PharmD, MHA Josiah D. Land, PharmD, BCOP Val R. Adams, PharmD, FCCP, BCOP

Activity Details Credit Amounts: CPE: 1.25 Other: 1.25 Type: Video Webcast Expires: Jun 19, 2018 Cost: Free E-mail Begin

Updates in Antiepileptic Therapy: Evaluating New Agents and Recent Evidence to Aid in the Selection of Treatment (2 User Ratings) Epilepsy is a spectrum of multiple neurologic disorders which are complex in diagnosis, management, and all phases of care.1 An estimated 2.9 million Americans are affected by epilepsy, and 1 in 26... Faculty Randa Jarrar, MD David M. Spencer, MD, FAAN

Activity Details Credit Amounts: CME: 1.25 CPE: 1.25 CNE: 1.25 Type: Video Webcast Expires: Dec 14, 2017 Cost: Free E-mail Begin

EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine (0 User Ratings) The discovery of epidermal growth factor receptor gene (EGFR) mutations in non–small cell lung cancer (NSCLC) and the development of EGFR tyrosine kinase inhibitors (TKIs) have dramatically transformed... Faculty Pasi A. Jänne, MD, PhD Mark G. Kris, MD, FACP, FACCP Lecia V. Sequist, MD, MPH Tony S. Mok, BMSc, MD, FRCPC Suresh S. Ramalingam, MD

Activity Details Credit Amounts: CME: 2.00 CPE: 2.00 CNE: 2.00 Other: 2.00 Type: PDF Expires: Jun 3, 2017 Cost: Free E-mail Begin

EXPERT EXCHANGE: Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors (0 User Ratings) Immune checkpoint inhibition (ICI) targeting cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 pathway (PD-1/PD-L1) has dramatically improved the care of patients with many... Faculty Jeffrey S. Weber, MD, PhD Naiyer A. Rizvi, MD Robert L. Ferris, MD, PhD Joaquim Bellmunt, MD, PhD

Activity Details Credit Amounts: CME: 2.00 CPE: 2.00 CNE: 2.00 Other: 2.00 Type: PDF Expires: Jun 2, 2017 Cost: Free E-mail Begin